SavedAdd your journal

Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2011 / Cilt: 20 - Sayı: 3

Lupus nefropatili bir hastada sistemik lupus eritematosusa bağlı gastrointestinal sistem vaskülopatisi

Systemic lupus erythematosus associated gastrointestinal system vasculopathy in a patient with lupus nephropathy

Özkan ULUTAŞ
Hülya TAŞKAPAN
Ercan GÜNDÜZ
Turgut PİŞKİN
Melda CÖMERT
Süleyman KOZ
Tamer BAYSAL
Pages
295–298
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here we report a 33-yearold SLE patient that presented with surgical acute abdomen symptoms, was followed-up in a Nephrology Department, and was well managed with high doses of corticosteroids and cyclophosphamide after the diagnosis of GIS vasculopathy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gastrointestinal system (GIS) manifestations are common in systemic lupus erythematosus (SLE) patients.
📊
Key Findings & Data:The gastrointestinal vasculopathy of SLE is a unique clinical entity and reviewed infrequently but it should be kept in mind to give the necessary treatment with corticosteroids and other immunosuppressive agents and to avoid non-essential surgical interventions.
💡
Conclusion & Impact:Here we report a 33-yearold SLE patient that presented with surgical acute abdomen symptoms, was followed-up in a Nephrology Department, and was well managed with high doses of corticosteroids and cyclophosphamide after the diagnosis of GIS vasculopathy.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gastrointestinal system (GIS) manifestations are common in systemic lupus erythematosus (SLE) patients. The gastrointestinal vasculopathy of SLE is a unique clinical entity and reviewed infrequently but it should be kept in mind to give the necessary treatment with corticosteroids and other immunosuppressive agents and to avoid non-essential surgical interventions. Here we report a 33-yearold SLE patient that presented with surgical acute abdomen symptoms, was followed-up in a Nephrology Department, and was well managed with high doses of corticosteroids and cyclophosphamide after the diagnosis of GIS vasculopathy.

Özet

Sistemik lupus eritematosus (SLE) hastalarında gastrointestinal sistem (GİS) semptomları sıktır. SLE' ye bağlı GİS vaskülopatisi daha önce literatürde az bildirilmiş nadir bir klinik durumdur fakat kortikosteroidler ve diğer immünosüpresiflerle doğru tedavinin verilmesi ve gereksiz cerrahi uygulamalardan kaçınılması açısından akılda tutulması gerekir. Burada SLE tanısıyla Nefroloji Bölümünde takip edilen ve akut batın semptomlarıyla başvuran 33 yaşındaki hastanın GİS vaskülopati tanısı konulduktan sonra yüksek doz kortikosteroid ve siklofosfamidle tedavisi anlatılmaktadır.

🔖

Cite This Article

ULUTAŞ, Ö., TAŞKAPAN, H., GÜNDÜZ, E., PİŞKİN, T., CÖMERT, M., KOZ, S., BAYSAL, T. (2022). Lupus nefropatili bir hastada sistemik lupus eritematosusa bağlı gastrointestinal sistem vaskülopatisi. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 20 - Sayı: 3, 295–298. https://ajindex.com/articles/636439

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nguyen H, Khanna N: Intestinal Pseudo-obstruction as a Presenting Manifestation of Systemic Lupus Erythematosus: Case Report and Rewiew of the Literature. Southern Medical Association, 2004
  2. 189 2. Leclair MA, Plaisance M, Balfour S, Touchette M: Chronic intestinal pseudo-obstruction in systemic lupus erythematosus. Canadian Journal of General Internal Medicine 2008
  3. 3(1): 18-20 3. Klippel JH: Systemic lupus erythematosus: Demographics, prognosis and outcome. J Rheumatol 1997
  4. 71 4. Grimbacher B, Huber M, Kempis J, Kalden P, Uhl M, Köhler G, Blum HE: Successful Treatment of Gastrointestinal Vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: A clinical case report and review of the literature. British Society for Rheumatology 1998
  5. 1028 5. Sultan SM, Ioannou Y, Isenberg DA: A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology 1999
  6. 932 6. Hallegua DS, Wallace DJ: Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol 2000
  7. 385 7. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, Koike T, Balestrieri G, Tincani A, Hughes GR, Meroni PL: Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-β2-glycoprotein I antibodies react in vitro with endothelial cells through adherent β2- glycoprotein I and induce endothelial activation. Arthritis Rheum 1997
  8. 561 8. Cervera R, Espinosa G, Cordero A, Oltra MR, Unzurrunzaga A, Rossiñol T, Plaza J, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J
  9. Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group: Intestinal involvement secondary to the antiphospholipid syndrome (APS): Clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. Semin. Arthritis Rheum 2007
  10. 296 9. Helliwell TR, Flook D, Whitworth J, Day DW: Arteritis and venulitis in systemic lupus erythematosus resulting in massive lower intestinal haemorrhage. Histopathology 1985
  11. 1113 10. Ju JH, Min JK, Jung CK, Oh SN, Kwok SK, Kang KY, Park KS, Ko H J, Yoon CH, Park SH, Cho SH, Kim HY: Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat Rev Rheumatol 2009
  12. 281 11. Ginzburg L, Klein E: Late intestinal stenosis following strangulated hernia. Ann Surg 1928
  13. 211 12. Drenkard C, Villa AR, Reyes E, Abello M, Alarcon-Segovia D: Vasc